6 unknown. 6 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Unknown 6 |
| Phase 3 | 2 | Unknown 2 |
Follow SARS-CoV2 Infection: new trials by email Literature Review of SARS-CoV2 Infection trials Research Report on SARS-CoV2 Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NAC for Attenuation of COVID-19 Symptomatology N-acetylcysteine, Placebo - Covid19, COVID-19 Pneumonia | Phase 2 | Unknown | Cambridge Health Alliance | 200 | 2024-03-31 | 2023-08-07 |
| Masitinib in Patients With Symptomatic Mild to Moderate COVID-19 Masitinib Mesylate, Placebo - Covid19, SARS-CoV2 Infection | Phase 2 | Unknown | AB Science | 78 | 2021-11-23 | 2023-02-06 |
| Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients Basiliximab Injection, Placebo - SARS-CoV-2 Acute Respiratory Disease, SARS-CoV2 Infection | Phase 2 | Unknown | Fort Worth Clinical Sciences Working Group | 300 | 2021-10-15 | 2021-08-19 |
| Efficacy and Safety of EXOSOME-MSC Therapy to Reduce Hyper-inflammation In Moderate COVID-19 Patients Exosome-MSC Intravenous injection, Placebo Intravenous Injection, COVID-19 Standard Treatment - SARS-CoV2 Infection | Phase 2 / Phase 3 | Unknown | Dermama Bioteknologi Laboratorium | 60 | 2021-07-01 | 2022-02-18 |
| Heterologous SARS-CoV-2 Vaccination With ChAdOx-1 and BNT162b2 Vaxzevria, Comirnaty - SARS-CoV2 Infection | Phase 2 | Unknown | Medical University Innsbruck | 3000 | 2021-05-10 | 2021-09-10 |
| Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection Nitazoxanide and Ciclésonide, Telmisartan 20Mg Oral Tablet, Paracetamol - Covid19, Covid19 Drug Treatment | Phase 2 / Phase 3 | Unknown | ANRS, Emerging Infectious Diseases | 600 | 2021-04-12 | 2023-01-31 |
COVID-19 (6) · Cytokine Release Syndrome (2)
Coronaviridae Infections (6) · Coronavirus Infections (6) · Infections (6) · Lung Diseases (6) · Nidovirales Infections (6) · Pneumonia (6) · Pneumonia, Viral (6) · RNA Virus Infections (6) · Respiratory Tract Diseases (6) · Respiratory Tract Infections (6) · Virus Diseases (6) · Inflammation (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Shock (2)
Acetaminophen (1) · Acetylcysteine (1) · BNT162 Vaccine (1) · Basiliximab (1) · ChAdOx1 nCoV-19 (1) · Fluoxetine (1) · Tablets (1) · Telmisartan (1) · masitinib (1) · nitazoxanide (1)
AB Science (1) · ANRS, Emerging Infectious Diseases (1) · Cambridge Health Alliance (1) · Dermama Bioteknologi Laboratorium (1) · Fort Worth Clinical Sciences Working Group (1) · Medical University Innsbruck (1)
Austria (1) · Burkina Faso (1) · France (1) · Guinea (1) · Indonesia (1) · Russia (1) · South Africa (1) · United States (1)
Bambang Darwono, Dr.Sp.OT (1) · Dorothee von Laer, MD (1) · Indah H Kampono, Dr. Sp.DV (1)